Evonik Acquires German Biotech JeNaCell
For an undisclosed sum, Germany’s Evonik has acquired German industrial biotech JeNaCell, thereby expanding its biomaterials portfolio to biotechnologically derived cellulose. The Essen-based group said the acquisition confirms its venture capital arm’s strategy of investing early in start-ups with visionary technology relevant to its own innovation growth fields.
